Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    An Enquiry

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Olanzapine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 820Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Minerva Neurosciences Reveals Roluperidone-Olanzapine Safety
    Minerva Neurosciences Reveals Roluperidone-Olanzapine Safety

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262573/32445/en/Minerva-Neurosciences-Presents-Data-from-its-Open-label-Safety-Trial-Evaluating-Roluperidone-Co-administered-with-Olanzapine-at-SIRS-2026.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    Anthea Pharma’s Generics Olanzapine Receives Approval in US
    Anthea Pharma’s Generics Olanzapine Receives Approval in US

    05 Mar 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220323

    FDA
    05 Mar 2026
    Share Share
    Omnivium Pharms’ Generics Olanzapine Receives Approval in US
    Omnivium Pharms’ Generics Olanzapine Receives Approval in US

    23 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219048

    FDA
    23 Jan 2026
    Share Share
    Teva Submits FDA Application For Olanzapine Injectable
    Teva Submits FDA Application For Olanzapine Injectable

    09 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202267/0/en/Teva-Pharmaceuticals-Submits-New-Drug-Application-to-FDA-for-Olanzapine-Extended-Release-Injectable-Suspension-TEV-749-for-the-Once-Monthly-Treatment-of-Schizophrenia-in-Adults.html

    GLOBENEWSWIRE
    09 Dec 2025
    Share Share
    Teva Reveals Promising SOLARIS Results for Olanzapine LAI
    Teva Reveals Promising SOLARIS Results for Olanzapine LAI

    23 Sep 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/diagnostic-center/teva-unveils-promising-solaris-resultsfor-olanzapine-lai-17853

    INDPHARMAPOST
    23 Sep 2025
    Share Share
    Medincell, Teva to Host Investor Call on Phase 3 Olanzapine LAI
    Medincell, Teva to Host Investor Call on Phase 3 Olanzapine LAI

    17 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-17/medincell-partner-teva-to-host-investor-call-on-completed-phase-3-olanzapine-lai-data-following-psyc

    PHARMAWEB
    17 Sep 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.